Here’s a structured collection of FAQs tailored for researchers working with MPK19 Antibody in plant molecular biology, based on current scientific literature and methodological rigor:
Methodological Answer:
Western Blot (WB): Use total protein extracts from wild-type (WT) and mpk19 knockout mutants. A specific band at the expected molecular weight (~50 kDa) in WT but not mutants confirms specificity .
ELISA: Coat plates with recombinant MPK19 protein (immunogen) and test antibody binding affinity. Include negative controls (e.g., unrelated plant proteins) to rule out cross-reactivity .
Immunolocalization: Combine with tissue-specific knockout lines to verify signal absence in mutants .
Methodological Answer:
Crosslinking: Use formaldehyde fixation to stabilize transient protein interactions before IP .
Buffer Optimization: Include phosphatase inhibitors (e.g., NaF) to preserve post-translational modifications and 1% Triton X-100 for membrane protein solubilization .
Validation: Perform IP followed by mass spectrometry to confirm MPK19-binding partners.
Methodological Answer:
Phylogenetic Analysis: Compare MPK19’s epitope regions with homologous MAP kinases (e.g., MPK4, MPK6) using Clustal Omega .
Epitope Mapping: Employ Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS) to identify discontinuous binding regions, as demonstrated for bacterial MntC antibodies .
Mutagenesis: Test antibody binding to MPK19 variants with key residue substitutions (e.g., phosphorylation sites) .
Methodological Answer:
Conditional Knockouts: Use tissue-specific promoters (e.g., CYCB1;1 for cell division) to isolate MPK19’s functions .
Phosphoproteomics: Compare phosphorylation patterns under stress (e.g., drought) vs. mitosis using Phos-tag SDS-PAGE .
Double Mutants: Analyze genetic interactions with mpk4 or mpk6 to disentangle overlapping pathways .
Low Signal in WB:
Non-specific Binding in IP:
Conflict: Some studies report MPK19 localization in the nucleus, others in the cytoplasm.
Resolution: